The Food and Drug Administration has given tentative approval to Viatris and Kindeva Drug Delivery for their Symbicort generic (budesonide/formoterol fumarate ...

The U.S. Food and Drug Administration on Tuesday approved the first generic Symbicort drug used to treat asthma and chronic obstructive pulmonary disease (COPD), which are two common pulmonary health ...

Mylan's proposed generic version of AstraZeneca's billion-dollar asthma drug gets another shot in patent case Lower court misinterpreted patents' terms, said divided Federal Circuit (Reuters) - Mylan ...

Iconovo, which develops complete inhalation products for a global market, is expanding its collaboration with Amneal for Symbicort in the ICOres inhaler to include additional territories with a ...

In the courtroom fracas over the patents on AstraZeneca’s multibillion-dollar inhaler Symbicort, Viatris and Kindeva Drug Delivery have toppled yet another intellectual property pillar. Still, ...

Mylan sued over generic of blockbuster AstraZeneca asthma drug Ruling ends one West Virginia case, another goes to trial in December (Reuters) - Viatris' Mylan Pharmaceuticals Inc cleared a hurdle ...

Full approval by the FDA follows tentative approval for the complex drug delivery advice for asthma and chronic obstructive pulmonary disease (COPD) granted by the FDA last week amid a patent dispute.